在癌症中长非编码RNA ANRIL
Aymeric Sanchez1, Julien Lhuillier1, Guillaume Grosjean2
1CNRS, Université de Lorraine, IMoPA, F-54000 Nancy, France.
Cancers
|August 26, 2023
概括
在INK4局部 (ANRIL) 中的反义非编码RNA对于基因调节和细胞过程至关重要. 它的失调与癌症有关,强调ANRILIL.
科学领域:
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- ANRIL (INK4局部中的反感性非编码RNA) 是位于人类染色体9p21区域的长非编码RNA.
- 安瑞尔通过与蛋白质和微RNA的相互作用来调节基因表达,影响细胞过程,如细胞周期控制和增殖.
- 异常ANRIL表达与各种疾病有关,特别是癌症和心血管疾病.
研究的目的:
- 审查9p21位点和ANRIL的监管机制.
- 阐明ANRIL在癌症发展中的致癌作用.
- 探索ANRIL作为瘤学诊断和预后生物标志物的潜力.
主要方法:
- 文献综述侧重于ANRIL的功能,调节和疾病相关性.
- 对研究9p21位点及其对基因表达的影响的研究分析.
- 对ANRIL参与瘤发生及其生物标志物潜力的当前研究的综合.
主要成果:
- 安利尔在调节基因表达方面发挥着重要作用,对细胞周期和增殖至关重要.
- 对ANRIL的失调是各种癌症的发病过程中经常出现的主题.
- 有证据表明,ANRIL作为癌症诊断和预后的生物标志物的潜在实用性.
结论:
- 安利尔是一种关键的调节剂,在癌症中起着显著的瘤作用.
- 了解ANRIL的机制为癌症生物学提供了洞察力.
- 在未来的癌症诊断和治疗中,ANRIL 是一个有前途的目标.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Types of RNA
5.9K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.9K
RNA Splicing
56.5K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.5K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K


